Delivery Order SPE2DB20D2014-SPE2DB25FC88D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,292.12 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,038.28 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a small-value pharmaceutical transaction under a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,432.43 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- This delivery order, awarded July 31, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 30 tablets of Veozah 45 mg with a ceiling value of $1,846.62 and completion date of August 1, 2025. The order represents a competitively awarded, firm fixed-price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,921.89 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Veozah 45 mg tablets (30-count packaging). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. The pharmaceutical product will be performed at the contractor's Conshohocken facility, with an ultimate completion date of August 1, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $12,719.67 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VEOZAH 45 mg tablets in 30-count packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Veozah 45 mg tablets (30-count) under a firm fixed-price contract valued at $13,694.27. The award was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded delivery order with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Veozah 45 mg tablets (30-count) under a firm fixed-price contract with a ceiling value of $3,479.11. This non-set-aside delivery order is scheduled for completion by August 1, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packaging) under a firm fixed-price contract valued at $7,199.04. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside contract represents a single delivery order for pharmaceutical product fulfillment, with performance to be completed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,496.63 on July 28, 2025, with a completion date of July 29, 2025. This non-set-aside contract procures VEOZAH 45 mg tablets in a 30-count package under a firm fixed-price arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC88DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,866.44 to AmerisourceBergen Drug Corp for 30-count tablets of Veozah 45 mg, a pharmaceutical product to support federal medical procurement needs. This non-set-aside, competitively awarded contract is classified as firm fixed price and was executed on September 2, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs and other federal health systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in fulfilling federal medical supply requirements across multiple therapeutic domains through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/2/25 |